← Leaderboards
Paolo Serafini
University Of Miami School Of Medicine
$2,304,023
Attributed
$3,567,760
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,567,760 · 5
By mechanism
UC4$1,964,641 · 1
R21$1,223,119 · 3
R56$380,000 · 1
Top collaborators
- Elizabeth Jane Franzmann2 shared
- Donald Topping Weed2 shared
- Midhat H Abdulreda1 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Elizabeth Jane Franzmann$3,381,587
- Midhat H Abdulreda$2,833,074
- Sanjoy K Bhattacharya$6,832,003
- Carlos Torres Moraes$23,681,039
- Alejandro Caicedo Vierkant$9,528,224
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCellsResistanceOligonucleotidesAptamerExperimental StudyRibonucleasesImmuneIn VivoClinicGenesLigandsSpecificityTumorAntigensMediatingSideVertebral ColumnMalignant NeoplasmsPathway InteractionsFutureNeoplastic CellPhenotypeDiagnosis
Grant awards (8)
PS03, a bifunctional RNA therapeutic to induce exhaustion in diabetogenic T cells$380,000
R56 · FY2025 · AI · contact PI
Aptamer specific for myeloid derived suppressor cells for the diagnosis of head and neck cancer from the oral rinse$230,250
R21 · FY2024 · DE · contact PI
Aptamer specific for myeloid derived suppressor cells for the diagnosis of head and neck cancer from the oral rinse$191,875
R21 · FY2023 · DE · contact PI
Aptamer mediated silencing of the spliceosome machinery to increase the immunogenicity of metastatic breast cancer$210,978
R21 · FY2022 · CA · contact PI
Aptamer mediated silencing of the spliceosome machinery to increase the immunogenicity of metastatic breast cancer$179,403
R21 · FY2021 · CA · contact PI
Aptamer chimeras for the in vivo modulation of beta cell mass and immunogenicity$1,964,641
UC4 · FY2017 · DK · contact PI
Antigen-specific tolerance in T1 diabetes by IDO loaded functionalized dendrimers$230,250
R21 · FY2014 · AI · contact PI
Antigen-specific tolerance in T1 diabetes by IDO loaded functionalized dendrimers$180,363
R21 · FY2013 · AI · contact PI